SLS: SELLAS Life Sciences Group, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 86.65
Enterprise Value ($M) 84.12
Book Value ($M) -7.98
Book Value / Share -0.14
Price / Book -10.86
NCAV ($M) -11.02
NCAV / Share -0.20
Price / NCAV -7.86

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.28
Return on Equity (ROE) -2.84

Liquidity (mrq)
Quick Ratio 0.23
Current Ratio 0.23

Balance Sheet (mrq) ($M)
Current Assets 3.17
Assets 6.22
Liabilities 14.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -37.87
Net Income -37.34
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -31.41
Cash from Investing -5.50
Cash from Financing 22.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-07 13G Highbridge Capital Management Llc 6.50

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-22 258,949 1,394,208 18.57
2024-04-19 674,119 194,433 346.71
2024-04-18 433,856 273,249 158.78
2024-04-17 141,609 563,827 25.12

(click for more detail)

Similar Companies
SEEL – Seelos Therapeutics, Inc. SHPH – Shuttle Pharmaceuticals Holdings, Inc.
SLRX – Salarius Pharmaceuticals, Inc. SMFL – Smart for Life, Inc.
SNDL – SNDL Inc.


Financial data and stock pages provided by
Fintel.io